Bumetanide for Alzheimer’s disease

Alzheimer’s disease is the most common form of dementia, affecting up to 70% of all people with dementia.1 In the early stages, symptoms can...

‘Don’t you know who I am?’: Why patient identification is so...

When we think patient safety, pharmacists’ minds jump to drug interactions, adverse events or toxic doses. But incorrect patient identification can have equal capacity...

PSA NT/SA Branch’s vaccine advocacy work

The PSA SA/NT Branch is fighting for pharmacists to be able to administer more vaccines. Read more about it here.

Pharmacists key to respiratory health in extreme weather

The recent dust storms and bushfires in NSW and Queensland serve as a reminder of the escalating effects of climate change, leading to an...

Informing pharmacy practice with valuable research

PSA’s Pharmacists in 2023 vision advocates the implementation of a ‘research culture’ in Australia. Here’s how members can pursue valuable research in their own...